Industry Leaders React to Historic Cannabis Rescheduling
President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...
A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.
Be the first to receive the Global Medical Cannabis Market Review 2026 when it publishes in January.
President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...
After two years of speculation, rumours, stock swings, broken promises, and political theatre, President Donald Trump officially signed an executive...
Europe’s leading cannabis policy, business and investment conference — bringing senior decision-makers together in Paris.
President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...
After two years of speculation, rumours, stock swings, broken promises, and political theatre, President Donald Trump officially signed an executive...
Cannabis Rescheduling fervour has once again reached dramatic levels following media reports that President Donald Trump is considering pushing through...
After a broadly optimistic and reform-driven 2024, this year saw momentum beging to shift once again for the global cannabis...
Business of Cannabis: New York 2025 arrived at a crucial moment not just for the local cannabis industry, but for...
Stenocare Danish medical cannabis oil producer Stenocare has exited its cultivation facility in Denmark, just four years after it was...
Canadian medical cannabis clinic Santé Cannabis has started recruitment for a new study assessing the effectiveness of various cannabis treatment...
Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has now issued the first three new licences for domestic cannabis...
The Cannabis Council of Canada (C3), the country’s most prominent lobbying group, has announced the appointment of industry veteran Paul...
Aurora Cannabis has agreed to settle a class action lawsuit regarding allegations it artificially inflated its profits in 2019. According...
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.